Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD
Gene Mutation Identified That Increases Lung Cancer Risk
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Gene Mutation Identified That Increases Lung Cancer Risk 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported .jpg)
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds 
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis 
